Home
>
National Drug Code (NDC)
>
Indomethacin
Indomethacin - 65977-5042-2 - (Indomethacin)
Drug Information of Indomethacin
| Product NDC: | 65977-5042 |
| Proprietary Name: | Indomethacin |
| Non Proprietary Name: | Indomethacin |
| Active Ingredient(s): | 25 mg/1 & nbsp; Indomethacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Indomethacin
| Product NDC: | 65977-5042 |
| Labeler Name: | Hetero Drugs Ltd., |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091240 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110412 |
Package Information of Indomethacin
| Package NDC: | 65977-5042-2 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (65977-5042-2) |
NDC Information of Indomethacin
| NDC Code | 65977-5042-2 |
| Proprietary Name | Indomethacin |
| Package Description | 500 CAPSULE in 1 BOTTLE (65977-5042-2) |
| Product NDC | 65977-5042 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Indomethacin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110412 |
| Marketing Category Name | ANDA |
| Labeler Name | Hetero Drugs Ltd., |
| Substance Name | INDOMETHACIN |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
